However, the chronic conditions that these plans typically address are increasingly understood to be interconnected manifestations of a shared underlying issue: metabolic dysfunction
These findings suggest that GLP treatment is associated with higher resting cardiovascular activation and reduced parasympathetic activity , indicating increased physiological load reported across studies[1]
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Your body uses a controlled level of inflammation to repair muscle, but alcohol adds an extra, unhelpful layer of it
If 8mg weekly produces excellent results with minimal side effects, there may be no benefit to pushing to 12mg if doing so causes substantial discomfort
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S